Trials / Completed
CompletedNCT01838291
Active Drug Surveillance Program of Ferriprox Use
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 294 (actual)
- Sponsor
- ApoPharma · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Observational, open label, prospective, multi-center, post-marketing drug surveillance program.
Detailed description
A post-marketing, drug surveillance program evaluating the use, monitoring, benefits and adverse effects of Ferriprox under clinical conditions in newly treated patients.
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2013-04-24
- Last updated
- 2013-04-24
Locations
14 sites across 5 countries: Cyprus, Egypt, Oman, Saudi Arabia, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01838291. Inclusion in this directory is not an endorsement.